Prediction of cytomegalovirus infection: A single‐center experience utilizing a newly available cell‐mediated immunity assay by flow cytometry, a risk factor screening tool, and serologically demonstrated immunity-Reference-Cited by-同舟云学术

Prediction of cytomegalovirus infection: A single‐center experience utilizing a newly available cell‐mediated immunity assay by flow cytometry, a risk factor screening tool, and serologically demonstrated immunity

Published:2020-05-22 Issue:4 Volume:22 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Jorgenson Margaret R.¹^ORCID,Hillis Mikala I.¹,Saddler Christopher M.²^ORCID,Smith Jeannina A.²,Parajuli Sandesh²^ORCID,Mandelbrot Didier A.²

Affiliation:

1. Department of Pharmacy University of Wisconsin Hospital and Clinics Madison WI USA

2. Department of Medicine University of Wisconsin‐Madison School of Medicine and Public Health University of Wisconsin Hospital and Clinics Madison WI USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13311

Reference30 articles.

1. Infection in Organ-Transplant Recipients

2. The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

3. Prospective follow-up of primary CMV infections after 6 months of valganciclovir prophylaxis in renal transplant recipients

4. Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients

5. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring cytomegalovirus prophylaxis based on T cell immunity panel assessment in kidney transplant patients at high risk of cytomegalovirus;Transplant Infectious Disease;2024-05-06

2. Using a commercially available assay that measures cytomegalovirus (CMV)-specific T-cell immunity to predict protection against CMV: A prospective, blinded clinical study;Diagnostic Microbiology and Infectious Disease;2024-02

3. Impact of high MELD scores on CMV viremia following liver transplantation;Transplant Infectious Disease;2023-01-10

4. A consensus conference to define the utility of advanced infectious disease diagnostics in solid organ transplant recipients;American Journal of Transplantation;2022-12

5. CMV antiviral stewardship: navigating obstacles to facilitate target attainment;Current Opinion in Organ Transplantation;2022-11-03